Multiple myeloma

Showing 9 of 0 results

• Flatiron Health announces research to be presented at the 2025 American Society of Hematology’s Annual Meeting & Exposition
  • Press releases
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
• Real-world insights into multiple myeloma management: An analysis of EHR-derived data in the UK and Germany

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Multiple myeloma
• What remains matters: Real-world impact of measurable residual disease testing in multiple myeloma

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Multiple myeloma
• The bispecific blind spot: Uncovering real-world inequities in diffuse large B-cell lymphoma, follicular lymphoma, and multiple myeloma therapy access

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
• Flatiron Health launches six new hematology AI-powered longitudinal datasets
  • Press releases
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
• Transportability of overall survival in multiple myeloma from the US to Germany: A benchmarking study

  ISPOR Europe

  • Publication summary
  • Publications
  • Multiple myeloma
• Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis

  Blood Cancer Journal

  • Publication summary
  • Publications
  • Clinical decision support
  • Treatment patterns
  • Multiple myeloma
• Design and methodological considerations for real-world data-derived progression-free survival in Multiple Myeloma

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Multiple myeloma
• Measurement error and bias in real-world oncology endpoints when constructing external control arms

  Frontiers in Drug Safety and Regulation

  • Publication summary
  • Publications
  • Methodology
  • Multiple myeloma